CVC Credit is pleased to announce that it has provided the debt facilities to support TPG's acquisition of DOC Generici, one of the leading suppliers of generic pharmaceuticals in Italy.
Founded in 1996, DOC Generici is a leading generic pharmaceutical company based in Milan, Italy. The company combines experience with specialisation to market a broad and expanding product portfolio with a strong presence in cardiovascular, GI, and neurological treatments. DOC Generici targets both doctors and pharmacies as routes to market, as well as end-users and wholesalers with a sales and marketing force consisting of more than 200 people.
Our aim is always to partner with top-quality sponsors and successful businesses, with stable revenue streams and strong cashflow generation, and DOC Generici is an excellent example of such a companyAndrew Davies
Simone Zacchi, Managing Director at CVC Credit, commented: "DOC Generici is well-positioned with a strong brand operating strategy and a broad and diverse product portfolio, and we are excited to support TPG's ambitions to enhance their leadership position further in the growing Italian generic pharmaceuticals market."
Andrew Davies, Partner and Co-Head of Private Credit at CVC Credit added: "We are delighted that, thanks to our relationship with the sponsor, we were approached by TPG to participate in this transaction. Our aim is always to partner with top-quality sponsors and successful businesses, with stable revenue streams and strong cashflow generation, and DOC Generici is an excellent example of such a company."